汉姆斯健康
HIMS
28.07
-1.31
-4.46%
汉姆斯健康
US · HIMS
#1813 按市值排名
上市于 1970
28.07
-1.31
-4.46%
实时 - 追踪5344个代码 - 心跳于354秒前
· 2026-10-16 19:59
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期(2026/Q3)披露持股的机构数量减少了1家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 67.54% +0.04pp
- 机构数量
- 593 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund46.57%
Individual/Insider8.36%
Hedge Fund8.05%
Public Company7.67%
Private Company1.98%
Government Pension Fund1.88%
VC/PE Fund0.62%
Family Office/Trust0.46%
Insurance Company0.27%
Other24.14%
主要股东 截至 2026-06-30
BlackRock
12.30% · 28.70M 股
Andrew Dudum
7.12% · 16.61M 股
Vanguard Capital Management, LLC
4.74% · 11.06M 股
Vanguard Portfolio Management, LLC
4.53% · 10.56M 股
State Street Global Advisors
3.49% · 8.15M 股
Morgan Stanley
2.90% · 6.76M 股
Divisadero Street Capital Management, LP
2.58% · 6.01M 股
Geode Capital Management, LLC
2.44% · 5.68M 股
The Goldman Sachs Group, Inc.
1.90% · 4.43M 股
FMR
1.85% · 4.32M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 21次买入 · 29次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Andrew Dudum | Chairperson & CEO | 7.12% |
| Melissa Baird | Chief Operating Officer | 0.35% |
| Mike Chi | Chief Marketing Officer | 0.20% |
| Soleil Boughton | Chief Legal Officer | 0.13% |
| Oluyemi Okupe | Chief Financial Officer | 0.10% |
| David Wells | Lead Independent Director | 0.10% |
| Patrick Carroll | Chief Medical Officer, Member of Medical Advisory Board & Director | 0.08% |
| Mohamed ElShenawy | Chief Technology Officer | 0.08% |
| Christopher Payne | Director | 0.06% |
| Andrea Perez Garcia | Independent Director | 0.04% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Oluyemi Okupe | Chief Financial Officer | Automatic Disposition | -2,000 | $29.70 |
| 2026-09-29 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -3,461 | $29.17 |
| 2026-09-21 | Oluyemi Okupe | Chief Financial Officer | Automatic Disposition | -15,277 | $29.95 |
| 2026-09-21 | Oluyemi Okupe | Chief Financial Officer | Derivative Exercise and Sale | -14,000 | $5.01–29.95 |
| 2026-09-16 | Oluyemi Okupe | Chief Financial Officer | Automatic Disposition | -12,313 | $28.82 |
| 2026-09-15 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -6,236 | $27.86 |
| 2026-09-14 | Mike Chi | Chief Marketing Officer | Automatic Disposition | -14,027 | $28.39 |
| 2026-09-14 | Mohamed ElShenawy | Chief Technology Officer | Automatic Disposition | -7,954 | $28.39 |
| 2026-09-01 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -3,458 | $28.33 |
| 2026-08-26 | Andrew Dudum | Chairperson & CEO | Other Disposition | -1,440,855 | -- |
| 2026-08-18 | Soleil Boughton | Chief Legal Officer | Automatic Disposition | -25,111 | $27.55 |
| 2026-08-18 | Oluyemi Okupe | Chief Financial Officer | Derivative Exercise and Sale | -4,938 | $5.01–29.99 |
| 2026-08-17 | Deborah Autor | Director | Automatic Disposition | -16,773 | $27.85 |
| 2026-08-16 | Oluyemi Okupe | Chief Financial Officer | Derivative Exercise and Sale | -9,388 | $5.01–27.89 |
| 2026-08-13 | Kare Schultz | Director | Derivative Exercise and Retained | +6,623 | -- |
| 2026-08-13 | David Wells | Lead Independent Director | Derivative Exercise and Retained | +778 | -- |
| 2026-08-13 | Deborah Autor | Director | Derivative Exercise and Sale | -16,147 | $28.15 |
| 2026-08-13 | Deborah Autor | Director | Derivative Exercise and Retained | +16,773 | -- |
| 2026-08-13 | Christopher Payne | Director | Derivative Exercise and Retained | +545 | -- |
| 2026-08-13 | Mike Chi | Chief Marketing Officer | Derivative Exercise and Sale | -47,702 | $28.15 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:59:34 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
汉姆斯健康 讨论区 0 条评论